Bristol-Myers Squibb Co (NYSE:BMY)
| 79.91 Delayed Data As of Dec 06 |  -0.80 / -0.99%Today’s Change | 56.11 Today|||52-Week Range 81.44 | +28.16% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 80.70 |
| Today’s open | 80.70 |
| Day’s range | 79.48 - 81.23 |
| Volume | 7,728,750 |
| Average volume (3 months) | 9,420,853 |
| Market cap | $172.5B |
Data as of 4:00pm ET, 12/06/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +1.21% |
| Earnings growth (next 5 years) | +4.57% |
| Revenue growth (last year) | +9.09% |
| P/E ratio | 26.0 |
| Price/Sales | 3.02 |
| Price/Book | 4.91 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | 0.00 | 0.00% |
| AZNAstraZeneca | +0.12 | +0.18% |
| NVONovo Nordisk | -0.02 | -0.02% |
| SNYSanofi | +3.62 | +8.06% |
Data as of 4:00pm ET, 12/06/2022
Financials
| Next reporting date | February 2, 2023 |
| EPS forecast (this quarter) | $1.74 |
| Annual revenue (last year) | $46.4B |
| Annual profit (last year) | $7.0B |
| Net profit margin | 15.08% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
